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Objective: To determine if there are significant differences in the temporal organization of rapid eye
movement (REM) sleep microarchitecture between healthy controls and outpatients with major depres-
sive disorder (MDD). Methods: Forty age-matched subjects, 20 men and 20 women, half with MDD,
were selected from an archive of sleep electroencephalography (EEG) data collected under identical con-
ditions. Each participant spent 2 consecutive nights in the Sleep Study Unit of the University of Texas
Southwestern Medical Center at Dallas, the first of which served as adaptation. The average amplitude in
each of 5 conventional EEG frequency bands was computed for each REM period across the second night.
Data were then coded for group and sex. Results: Aside from REM latency, none of the key sleep
macroarchitectural variables differentiated MDD patients from controls. REM latency was longest in men
with MDD. Sleep microarchitecture, however, did show a number of between-group differences. In gen-
eral, slower frequencies declined across REM periods, with a significant REM period effect for delta, theta
and alpha amplitude. Group × sex interactions were also obtained for theta and alpha. Beta activity
showed a unique temporal profile in each group, supported by a significant REM period × group × sex
interaction. In addition, the temporal change in theta amplitude across REM periods was most striking in
women with MDD. Conclusions: This study suggests that, like during non-REM sleep, EEG amplitude
shows a systematic temporal change over successive REM sleep periods and also shows elements that are
both disease- and sex-dependent.
Objectif : Déterminer s’il y a des différences significatives dans l’organisation temporelle de la micro-archi-
tecture du sommeil paradoxal entre des témoins en bonne santé et des patients en service externe atteints
de trouble dépressif majeur (TDM). Méthodes : Quarante sujets jumelés selon l’âge, soit 20 hommes et 20
femmes, dont la moitié étaient atteints de TDM, ont été choisis dans une archive de données élec-
troencéphalographiques (EEG) sur le sommeil recueillies dans des conditions identiques. Chaque participant
a passé deux nuits consécutives à l’Unité d’étude du sommeil du Centre médical de l’Université du sud-
ouest du Texas à Dallas, dont la première a servi de période d’adaptation. On a calculé l’amplitude moyenne
de chacune des cinq bandes classiques de fréquence EEG pour chaque période de sommeil paradoxal au
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Introduction
There is ample evidence that the timing or distribution
of rapid eye movement (REM) sleep and non-REM
sleep stages are disrupted in those with major de-
pressive disorders (MDD).1–3 Moreover, the micro-
architecture of sleep based on quantitative electro-
encephalographic (EEG) analysis shows a number of
abnormalities in patients with MDD. Elevated fast-
frequency, decreased slow-wave activity and dysregu-
lation of ultradian sleep EEG rhythms have all been
reported as characteristic of those with MDD.4–10 Recent
work also indicates that it is primarily men with MDD
who show an aberrant time course of slow-wave activ-
ity in non-REM sleep, whereas women with MDD are
more likely to show ultradian rhythm abnormalities.5
Most quantitative sleep EEG studies in MDD, how-
ever, have focused on non-REM sleep. To date, it is not
clear whether these sex differences are also evident in
REM sleep. Since women are at twice the lifetime risk of
men for developing depression and since that risk occurs
mainly during the reproductive years, it is reasonable to
assume that there are biological factors that contribute to
risk of depression.11 Sleep EEG studies provide some of
the strongest support for the biological basis of depres-
sion and certainly present an ideal opportunity to inves-
tigate why women are at greater risk. Unfortunately,
only a handful of sleep studies have assessed potential
sex differences in depression or in healthy controls.12
The purpose of this preliminary report was to inves-
tigate potential sex differences in the temporal organi-
zation of REM sleep in depressed individuals and in
healthy controls. It was expected that sex differences in
the group with MDD would be larger than those ob-
served in healthy adults.
Methods
The subjects were divided into groups on the basis of
clinical diagnosis and sex. All participants were right-
handed. The normal control (NC) group consisted of
10 men, 25–40 years of age (mean 30.8 [standard devia-
tion (SD) 6.0] yr) and 10 women, 22–40 years of age
(mean 30.4 [SD 5.0] yr). The MDD group consisted of
10 men, 22–40 years of age (mean 30.1 [SD 5.3] yr) and
10 women, 22–39 years of age (mean 30.6 [SD 5.4] yr).
Outpatients who met criteria for nonpsychotic major
depression (single or recurrent) but were otherwise
physically healthy comprised the MDD group. Diag-
noses were based on the Structured Clinical Interview
for DSM-III-R (SCID)13 or DSM-IV.14 Patients were
mild-to-moderately ill, with an average score of 21.4
(SD 3.9) on the 17-item Hamilton rating scale for de-
pression (minimum 17). They were also medication
free for a minimum of 2 weeks before the study
(4 weeks for monoamine oxidase inhibitors, 6 weeks
for fluoxetine). Other current Axis I disorders, current
general medical conditions or substance abuse 12
months before baseline excluded subjects. All control
subjects were medically fit and had no personal family
history of Axis I disorders or substance abuse based on
the SCID-NP (non-patient version). Independent sleep
disorders such as narcolepsy, sleep apnea and bruxism
were ruled out by medical history or polysomnogram.
Shift work was also exclusionary.
Procedure
Each participant spent 2 consecutive nights in the Uni-
versity of Texas Southwestern Medical Center Sleep
Study Unit, the first of which served as laboratory
cours de la deuxième nuit. On a ensuite codé les données selon le groupe et le sexe. Résultats : Outre la
latence du sommeil paradoxal, aucune des variables macro-architecturales clés du sommeil n’a permis de
distinguer les patients atteints de TDM des sujets témoins. La latence du sommeil paradoxal a été la plus
longue chez les hommes atteints de TDM. La micro-architecture du sommeil a toutefois révélé des
différences entre les groupes. En général, les fréquences plus lentes diminuaient au cours des périodes de
sommeil paradoxal et l’amplitude des ondes delta, theta et alpha avait un effet important sur la période du
sommeil paradoxal. On a aussi tiré des ondes theta et alpha des interactions groupe-sexe. L’activité beta a
révélé un profil temporel singulier dans chaque groupe, appuyé par un lien groupe-sexe important pendant la
période de sommeil paradoxal. En outre, le changement temporel de l’amplitude des ondes theta pendant
les périodes de sommeil paradoxal a été le plus frappant chez les femmes atteintes de TDM. Conclusions :
Cette étude indique que, comme pendant le sommeil non paradoxal, l’amplitude EEG montre un change-
ment temporel systématique pendant des périodes successives de sommeil paradoxal et montre aussi des
éléments qui sont liés à la fois à la maladie et au sexe.
adaptation. All participants maintained regular bed-
and rise-times for 5 days before the study, and this was
verified by home diary. This habitual sleep schedule
was also followed in the laboratory. Any subject with
more than a half-hour of deviation in sleep schedule
during the 5 days was excluded from the study. Sub-
jects entered the laboratory for electrode application
approximately 1.5 hours before the scheduled bedtime.
The electrode montage included left (C3) and right
(C4) central EEG, left and right electro-oculograms
(EOG) recorded from the upper and lower canthi, and
a bipolar, chin–cheek electromyogram (EMG). The first
night also served as an additional screening for inde-
pendent sleep disorders (e.g., apnea, bruxism and peri-
odic limb movements) and included leg leads, chest
and abdomen respiration bands and a nasal–oral ther-
mistor in the electrode montage. EEG electrodes were
referenced to the earlobes connected to a 10-kΩ resistor
to minimize nonhomogeneous current flow and poten-
tial artifactual hemispheric asymmetries,15 as is stan-
dard in our laboratory. EEG was transduced by GRASS
P511 A/C amplifiers set at a sensitivity of 5 (50 µV,
0.5-s calibration), corresponding to a gain of 50 000.
The half-amp low- and high-bandpass filters were set
at 0.3 Hz and 30 Hz, respectively. A 60-Hz notch filter
attenuated electrical noise. Signals were digitized on-
line at 250 Hz (62.5 Hz for EOG and EMG) through a
16-bit MICROSTAR analogue-to-digital polygraph
system, which was designed and validated in-house.
Signal processing
Period amplitude analysis (PAA) was used to quantify
EEG activity and has been described in detail else-
where.3,15–17 Briefly, PAA evaluates wave incidence and
amplitude 250 times/s and accumulates over 30 s in
each of delta (0.5 Hz to below 4 Hz), theta (4 Hz to
below 8 Hz), alpha (8 Hz to below 12 Hz), sigma
(12 Hz to below 16 Hz) and beta (16 Hz to below
32 Hz) frequency bands. For the purpose of this report,
EEG amplitude (in µV2) in each frequency band was
averaged across C3 and C4 electrodes.
Sleep records were scored from C3 electrodes in 30-s
epochs, according to standard criteria,18 by research
personnel trained at better than 90% agreement on an
epoch-by-epoch basis. Scorers were blind to the clinical
status and sex of study participants. Note that both
computer and human evaluation of sleep EEG were
based on identical 30-s epochs. All records were
inspected visually, and epochs containing movement,
breathing or muscle artifact or recording difficulties
were excluded from the analysis. An average of 7.8
(SD 2.1) epochs were excluded, resulting in the loss of
less than 5 minutes of EEG data over the 7- to 8-hour
recording period, in any individual record.
Data analysis
The REM periods were defined by 3 rules. First, a mini-
mum 3-minute duration was required to begin a REM
period. At least 10 consecutive epochs of non-REM or
awake were required to terminate a single REM period.
This criterion was chosen to be comparable with non-
REM period definitions in previous work. Second, sub-
sequent REM periods had to be at least 60 epochs (i.e.,
30 min) after the preceding REM period, in accordance
with the rules of Rechtschaffen and Kales.18 Finally, the
last REM period had to end either in accordance with
the rules above or terminated by the morning awaken-
ing. After each REM period was defined, amplitude
and incidence measures were summed and averaged
for each subject. Note that because intervening wake,
movement and non-REM epochs do occur within each
REM period, all amplitude measures were based only
on the REM epochs (i.e., net REM) within each REM
period. Thus, the definition dictated that a minimum of
75 000 samples (250 Hz × 30 s × 5 min) would be avail-
able in which amplitude could be evaluated in each
REM period. For statistical purposes, only the first 3
REM periods were included for analysis because only
some of the participants had 4 or more complete REM
periods for the night.
Data were then coded for group (MDD or NC) and
sex. Repeated-measures analyses of variance
(ANOVAS) were computed, treating REM period as a
3-level repeated measure and group and sex as be-
tween-group variables. Between-group interactions
were tested first, followed by between-group main
effects if no interaction was evident. Least-squares
multiple comparisons tested differences between indi-
vidual means at an experiment-wise p < 0.05, to pro-
tect against possible type I errors.
Results
Although overall sleep microarchitecture was more
disturbed in the MDD group, none of the group main
effects reached statistical significance (p > 0.05). Group
Liscombe et al
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× sex interactions were obtained for REM latency (p <
0.04), and multiple comparisons confirmed longer
REM latency in men with MDD than in women with
MDD and NC men (p < 0.02). As seen in Table 1,
women with MDD had more slow-wave (stage 3 and
4) sleep, but this difference only approached signifi-
cance (p < 0.08). Further, the latencies and durations of
individual REM periods did not differ between groups.
As a result, no further analyses were conducted on
these measures.
Sleep microarchitecture, however, did show a num-
ber of between-group differences. The means and SDs
for sigma, alpha and delta amplitude measures are
shown in Table 2. Between-group differences in theta
Table 1: Sleep stage variables for patients with major depressive disorder and controls










Total sleep period, min 410.6 (38.7) 426.0 (36.5) 444.9 (56.7) 418.6 (39.7)
Sleep latency, min 18.7 (21.9) 8.2 (6.2) 13.3 (8.7) 16.8 (9.5)
Sleep efficiency, TSP/TIB 90.7 (4.4) 97.3 (2.6) 96.1 (3.3) 89.7 (2.4)
% stage 1 in TSP 15.8 (7.9) 13.9 (4.9) 18.2 (5.4) 14.8 (7.7)
% stage 2 in TSP 55.1 (6.8) 56.6 (5.3) 53.4 (8.1) 49.8 (9.5)
% stages 3 and 4 in TSP 5.0 (5.1) 4.8 (5.6) 3.7 (5.2) 10.2 (7.0)
% REM in TSP 18.8 (4.4) 20.5 (3.7) 18.6 (4.8) 18.6 (6.3)
REM density 2.6 (0.7) 2.3 (0.7) 2.6 (0.7) 2.2 (0.6)
Note: SD = standard deviation, MDD = major depressive disorder, TSP = total sleep period, TIB = time in bed, REM = rapid eye movement.
Table 2: REM period characteristics by sex and group
Group, mean (and SD)
Period, variable Male controls Female controls Men with MDD Women with MDD
REM period 1
Latency, min 64.4 (11.2) 78.0 (24.8) 89.7 (28.1) 66.6 (10.9)
Duration, min 14.5 (9.1) 12.6 (8.9) 24.5 (18.7) 16.4 (8.3)
Net REM, min 10.1 (5.8) 11.0 (8.7) 18.5 (15.0) 11.5 (3.5)
Excluded, min 4.4 (5.3) 1.6 (2.0) 6.0 (4.2) 4.9 (7.5)
Sigma, µV2 17.1 (6.4) 16.8 (6.4) 14.7 (4.3) 17.9 (6.3)
Alpha, µV2 37.4 (13.5) 32.6 (12.6) 25.5 (8.6) 38.7 (8.1)
Delta, µV2 307.9 (57.5) 368.2 (102.9) 275.4 (88.0) 341.6 (71.6)
REM period 2
Latency, min 153.1 (27.3) 159.2 (46.7) 192.1 (53.7) 156.4 (17.2)
Duration, min 21.0 (8.3) 27.4 (9.2) 26.1 (8.0) 26.2 (13.2)
Net REM, min 15.0 (8.7) 18.2 (4.9) 19.3 (6.8) 20.3 (10.9)
Excluded, min 6.0 (2.5) 9.2 (7.3) 6.8 (7.6) 5.9 (6.5)
Sigma, µV2 14.5 (5.2) 14.8 (4.4) 12.7 (5.2) 16.7 (4.8)
Alpha, µV2 31.6 (10.7) 29.6 (10.8) 22.9 (8.6) 35.4 (6.7)
Delta, µV2 306.4 (73.7) 309.8 (16.7) 261.4 (80.6) 320.9 (53.2)
REM period 3
Latency, min 245.1 (37.0) 260.5 (43.3) 300.8 (57.2) 288.8 (62.9)
Duration, min 37.8 (21.0) 28.6 (18.1) 38.1 (12.5) 38.9 (11.9)
Net REM, min 27.8 (14.6) 22.5 (12.5) 27.6 (13.9) 23.2 (9.7)
Excluded, min 10.0 (7.2) 6.1 (6.5) 10.5 (8.0) 7.7 (5.7)
Sigma, µV2 14.9 (4.8) 13.9 (3.4) 12.7 (5.0) 15.9 (4.5)
Alpha, µV2 33.8 (10.4) 27.6 (9.0) 22.6 (8.3) 34.5 (5.5)
Delta, µV2 266.3 (49.8) 311.1 (65.0) 244.5 (79.5) 319.6 (45.5)
* Note that the duration of each REM period is the net REM plus the minutes of other stages that were excluded from calculation of average power (i.e., Duration = Net
REM + Excluded).
and beta amplitude are illustrated in Fig. 1 and Fig. 2,
respectively. A significant REM period repeated-
measures effect was evident for delta amplitude (p <
0.01). Significant REM period and group × sex effects
were also obtained for theta amplitude (p < 0.0003 and
p < 0.02, respectively) and alpha amplitude (p < 0.002
and p < 0.005, respectively). Beta amplitude showed a
group × sex × REM period interaction (p < 0.04).
In general, EEG amplitude in slower frequencies
showed a decline across successive REM periods.
Women in both MDD and NC groups had higher over-
all delta amplitude than their male counterparts,
confirmed by multiple comparisons (p < 0.05). This
effect was restricted to the first REM period. Moreover,
the repeated-measure effect (i.e., the decline in delta
over REM period) was larger than the sex difference.
With regard to alpha amplitude, men with MDD had
lower alpha amplitude than MDD women in all 3 REM
periods (p < 0.05). Multiple comparisons also con-
firmed higher theta amplitude in the women with
MDD compared with all other groups for each REM
period (p < 0.01). Women with MDD also showed a
stronger decline over the REM sleep periods.
By contrast, each group showed distinct and differ-
ent temporal changes in fast-frequency activity. Beta
amplitude was higher in MDD groups than in the
corresponding NC groups, as expected from previous
work. However, MDD men had higher beta amplitude
than MDD women in the first REM period, an effect
that reversed by the second REM period, with no sex
difference in the third REM period. Moreover, sex
differences in the NC group were in the opposite direc-
tion. None of the between-group multiple comparisons
were significant, indicating that is the pattern of
change across REM periods (i.e., the repeated measure)
that differentiated the groups and produced the signifi-
cant group × sex interaction (Fig. 2).
Discussion
The results of this study suggest that, like non-REM
sleep, EEG amplitude shows a systematic temporal
change over successive REM sleep periods, particularly
for delta amplitude. Theta amplitude also declined
over REM periods, but the effects were most pro-
nounced in women with MDD. The trends, however,
appear less systematic in faster frequency bands with a
unique temporal profile in each group. Temporal
changes in beta and theta amplitude also showed
stronger sex differences in the MDD group than in the
NC group. These findings are in general agreement
with our previous studies identifying robust group ×
sex interactions in non-REM sleep EEG5,19 and provide
further evidence that the pathophysiology of depres-
sion differs in men and women.
The strong results reported here are remarkably con-
cordant with the results and conclusions of Antonijevic
et al.20,21 In fact, both sleep macro- and microarchitec-
ture data from the 2 research groups are quite similar.
In addition, Antonijevic et al21 have suggested a sexual
Liscombe et al
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Fig. 1: Average theta (4.0–8.0 Hz) amplitude in the first
3 REM periods by sex and group (n = 10 per group). See
Table 2 (net REM min) for average sample length per
REM period.
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Fig. 2: Average beta (16–32 Hz) amplitude in the first 3
REM periods by sex and group (n = 10 per group).
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dimorphism in neuroendocrine function that is dis-
ease-dependent. It may very well contribute to the sex
differences in sleep and depression between men and
women. Further support for this notion has come from
Rubin and colleagues,22,23 who have demonstrated sex-
ual dimorphism in cholinergic neurotransmitter func-
tion and hypothalamic-pituitary-adrenal axis activity
in depression. Moreover, recent reviews have high-
lighted a number of sex differences in sleep and mood
regulation that are related to gonadal hormone regula-
tion.11,12 These biological factors may contribute to the
sex difference observed here and in other studies.
Our results also suggest a dynamic temporal organi-
zation of EEG activity in REM sleep like that demon-
strated in non-REM sleep in numerous studies of
healthy individuals.24–29 A caveat may be necessary,
however, since the temporal organization is influenced
by group and sex.6
There were some surprising findings in this study.
First, enhanced theta amplitude might be expected to
occur in longer duration, more phasic REM periods.17
Thus, higher theta amplitude would be expected in the
latter REM periods of the night. By contrast, these data
show a decline in theta amplitude over REM sleep in
all groups. The meaning of such an outcome is not
clear, although Corsi-Cabrera et al30 suggest that theta
oscillations are under the same gonadal influence as
delta and, therefore, should mirror the temporal char-
acteristics of the latter.
Investigating the temporal organization of sleep EEG
across successive REM periods may provide a sensitive
means of discriminating between depressed and
healthy individuals and between the sexes. It remains
to be demonstrated, nonetheless, whether temporal or-
ganization of EEG microarchitecture in REM sleep falls
under homeostatic regulation and shows the same re-
sponse to sleep deprivation and extending prior wake-
fulness as slow-wave activity in non-REM sleep. Cer-
tainly, there is some evidence that this may be the case
in healthy individuals. Our future work will evaluate
this possibility in individuals with MDD. If the findings
of this preliminary report are confirmed, it suggests that
the temporal dynamics of both REM and non-REM
sleep EEG are both disease- and sex-dependent.
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DA function: a model for the opposing effects of
stress on motivated behaviour
Jock Cleghorn Award
Mr. Steven Szabo is the recipient of the 2001 CCNP
Jock Cleghorn Prize. Mr. Szabo is doing research
training in the Department of Psychiatry, University
of Florida in Gainsville, Fla. This award is designed
to recognize the best poster presentation by a re-
search trainee at the CCNP Annual Meeting. The
award, donated by the CCNP, consists of $500. Con-
gratulations to Mr. Szabo!
Presentation: Serotonin receptor effects on nor-
ephinephrine neuron firing are mediated through
excitatory amino acid and GABA-A receptors
Innovations in Neuropsychopharmacology
Award
Dr. Harold A. Robertson is the recipient of the
2001 CCNP Innovations in Neuropsycho-
pharmacology Award. Dr. Robertson is cur-
rently professor and head of the Department of
Pharmacology, Faculty of Medicine, Dalhousie
University in Halifax. This award is designed to
recognize outstanding research innovations in
the basic or clinical fields of neuropsychophar-
macology. The award, donated by Pfizer Canada
Inc., consists of $5000 and an engraved plaque.
Congratulations to Dr. Robertson!
Presentation: The genome and the brain: towards
a neurobiology of psychiatric disorders
Young Investigator Award
Dr. Ridha Joober is the recipient of the 2001
CCNP Young Investigator Award. Dr. Joober is
currently an assistant professor in the Depart-
ment of Psychiatry and associate member in the
Department of Neurology and Neurosurgery at
McGill University. The award, donated by Bris-
tol-Myers Squibb Company, consists of a $2500
bursary plus a $2000 research grant and an en-
graved plaque. Congratulations to Dr. Joober!
Presentation: Genetics of schizophrenia: com-
bining animal models and clinical studies
